mixing semaglutide and tirzepatide Switching from to Tirzepatide: What You Need to Know The Ultimate Guide to Weight

The 4 mg maintenance dose produced 17.1% average weight loss across the full trial population, but lighter individuals within that group often experienced responses closer to 20% or higher

Rita Kathawa, M.D., M.A., dual board-certified in Internal Medicine and Obesity Medicine

weight loss (Phase 2/3 peak) | ~15% | ~22% | ~24% | | FDA Status | Approved (Wegovy, Ozempic) | Approved (Zepbound, Mounjaro) | Phase 3 (2026) | | Dosing frequency | Weekly | Weekly | Weekly | The additional glucagon receptor agonism is believed to be responsible for retatrutide's greater metabolic rate increase and enhanced fat oxidation compared to dual agonists

Choline: A vital nutrient that supports liver function and assists in the transportation and metabolism of fats

Were proud to have a certified therapist on staff who performs this highly specialized technique